Erythrophagocytosis of lead-exposed erythrocytes by renal tubular cells: Possible role in lead-induced nephrotoxicity

Environmental Health Perspectives

Volumn 123, Issue 2, 2015, Pages 120-127

  Kwon, So Youn ^a   Bae, Ok Nam ^b   Noh, Ji Yoon ^a   Kim, Keunyoung ^a   Kang, Seojin ^a   Shin, Young Jun ^b   Lim, Kyung Min ^c   Chung, Jin Ho ^a  

^a Seoul National University   (South Korea)

^b Hanyang University   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

KIDNEY INJURY MOLECULE 1; LIPOCORTIN 5; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; BIOLOGICAL MARKER; DANGEROUS GOODS; IRON; LEAD;

ADULT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL VIABILITY; CYTOTOXICITY; ELECTRON MICROSCOPY; ENZYME KINETICS; ERYTHROCYTE; ERYTHROPHAGOCYTOSIS; FIBROSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KIDNEY INJURY; KIDNEY TUBULE CELL; LEAD INDUCED NEPHROTOXICITY; MALE; MTT ASSAY; NEPHROTOXICITY; NONHUMAN; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; CHEMICALLY INDUCED; CYTOLOGY; DANGEROUS GOODS; DRUG EFFECTS; ERYTHROCYTE MEMBRANE; KIDNEY; KIDNEY DISEASE; METABOLISM; PHAGOCYTOSIS; SPRAGUE DAWLEY RAT; TOXICITY;

PHAGO; RATTUS;

ANIMALS; BIOMARKERS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FLOW CYTOMETRY; HAZARDOUS SUBSTANCES; HUMANS; IRON; KIDNEY; KIDNEY DISEASES; LEAD; MALE; OXIDATIVE STRESS; PHAGOCYTOSIS; PHOSPHATIDYLSERINES; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84923043716     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1408094     Document Type: Article

References (58)

1. ATSDR (Agency for Toxic Substances and Disease Registry). 2007. Toxicological Profile for Lead. Atlanta, GA:ATSDR. Available: http://www.atsdr.cdc.gov/ToxProfiles/tp13.pdf [accessed 5 January 2015].
2. Bonomini M, Sirolli V, Reale M, Arduini A. 2001. Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythro-cytes. Am J Kidney Dis 37:807-814.
3. Bonomini M, Sirolli V, Settefrati N, Dottori S, Di Liberato L, Arduini A. 1999. Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol 10:1982-1990.
4. CDC (Centers for Disease Control and Prevention). 1997. Screening Young Children for Lead Poisoning: Guidance for State and Local Public Health Officials. Atlanta, GA:CDC. Available: http://www. cdc.gov/nceh/lead/publications/screening.htm [accessed 5 January 2015].
5. CDC (Centers for Disease Control and Prevention). 2013. Very high blood lead levels among adults— United States, 2002-2011. MMWR Morb Mortal Wkly Rep 62:967-971.
6. Cramér K, Goyer RA, Jagenburg R, Wilson MH. 1974. Renal ultrastructure, renal function, and parame ters of lead toxicity in workers with different periods of lead exposure. Br J Ind Med 31:113-127.
7. Daggett DA, Oberley TD, Nelson SA, Wright LS, Kornguth SE, Siegel FL. 1998. Effects of lead on rat kidney and liver: GST expression and oxidative stress. Toxicology 128:191-206.
8. Diamond GL. 2005. Risk assessment of nephrotoxic metals. In: The Toxicology of the Kidney (Tarloff J, Lash L, eds). London:CRC Press, 1099-1132.
9. Eddy AA. 1996. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495-2508.
10. Ekong EB, Jaar BG, Weaver VM. 2006. Lead-related nephrotoxicity: a review of the epidemiologic evidence. Kidney Int 70:2074-2084.
11. Fadrowski JJ, Navas-Acien A, Tellez-Plaza M, Guallar E, Weaver VM, Furth SL. 2010. Blood lead level and kidney function in US adolescents: the Third National Health and Nutrition Examination Survey. Arch Intern Med 170:75-82.
12. Fens MH, van Wijk R, Andringa G, van Rooijen KL, Dijstelbloem HM, Rasmussen JT, et al. 2012. A role for activated endothelial cells in red blood cell clearance: implications for vasopathology. Haematologica 97:500-508.
13. Fowler BA, Kimmel CA, Woods JS, McConnell EE, Grant LD. 1980. Chronic low-level lead toxicity in the rat. III. An integrated assessment of long-term toxicity with special reference to the kidney. Toxicol Appl Pharmacol 56:59-77.
14. Fraga CG, Oteiza PI. 2002. Iron toxicity and antioxidant nutrients. Toxicology 180:23-32.
15. Goyer RA. 1989. Mechanisms of lead and cadmium nephrotoxicity. Toxicol Lett 46:153-162.
16. Hernández-Avila M, Smith D, Meneses F, Sanin LH, Hu H. 1998. The influence of bone and blood lead on plasma lead levels in environmentally exposed adults. Environ Health Perspect 106:473-477.
17. Hernberg S. 2000. Lead poisoning in a historical perspective. Am J Ind Med 38:244-254.
18. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. 2008. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 118:1657-1668.
19. Isaka Y, Tsujie M, Ando Y, Nakamura H, Kaneda Y, Imai E, et al. 2000. Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58:1885-1892.
20. Jang WH, Lim KM, Kim K, Noh JY, Kang S, Chang YK, et al. 2011. Low level of lead can induce phosphati-dylserine exposure and erythrophagocytosis: a new mechanism underlying lead-associated anemia. Toxicol Sci 122:177-184.
21. Kempe DS, Lang PA, Eisele K, Klarl BA, Wieder T, Huber SM, et al. 2005. Stimulation of erythrocyte phosphatidylserine exposure by lead ions. Am J Physiol Cell Physiol 288:C396-C402.
22. Knutson M, Wessling-Resnick M. 2003. Iron metabo-lism in the reticuloendothelial system. Crit Rev Biochem Mol Biol 38:61-88.
23. Kobayashi N, Karisola P, Peña-Cruz V, Dorfman DM, Jinushi M, Umetsu SE, et al. 2007. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27:927-940.
24. Kong QY, Wu X, Li J, Peng WX, Ye R, Lindholm B, et al. 2001. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients. Adv Perit Dial 17:58-60.
25. Kovtunovych G, Eckhaus MA, Ghosh MC, Ollivierre- Wilson H, Rouault TA. 2010. Dysfunction of the heme recycling system in heme oxygenase 1- deficient mice: effects on macrophage viability and tissue iron distribution. Blood 116:6054-6062.
26. LeBleu VS, Taduri G, O’Connell J, Teng Y, Cooke VG, Woda C, et al. 2013. Origin and function of myofibro-blasts in kidney fibrosis. Nat Med 19:1047-1053.
27. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY. 2002. Smad7 inhibits fibrotic effect of TGF-β on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 13:1464-1472.
28. Liu CM, Ma JQ, Sun YZ. 2012a. Puerarin protects rat kidney from lead-induced apoptosis by modu-lating the PI3K/Akt/eNOS pathway. Toxicol Appl Pharmacol 258:330-342.
29. Liu CM, Sun YZ, Sun JM, Ma JQ, Cheng C. 2012b. Protective role of quercetin against lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKS and NF-κB pathway. Biochim Biophys Acta 1820:1693-1703.
30. Lock EA. 2010. Sensitive and early markers of renal injury: where are we and what is the way forward? Toxicol Sci 116:1-4.
31. Loghman-Adham M. 1997. Renal effects of environ-mental and occupational lead exposure. Environ Health Perspect 105:928-938.
32. Madsen KM, Applegate CW, Tisher CC. 1982. Phagocytosis of erythrocytes by the proximal tubule of the rat kidney. Cell Tissue Res 226:363-374.
33. Mahaffey KR, Rader JI, Schaefer JM, Kramer SN. 1980. Comparative toxicity to rats of lead acetate from food or water. Bull Environ Contam Toxicol 25:541-546.
34. Mercer J, Helenius A. 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-535.
35. Mimura I, Tojo A, Uozaki H, Fujita T. 2008. Erythro-phago cytosis by renal tubular cells. Kidney Int 74:398; doi:10.1038/sj.ki.5002789.
36. Muntner P, He J, Vupputuri S, Coresh J, Batuman V. 2003. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney Int 63:1044-1050.
37. Navas-Acien A, Tellez-Plaza M, Guallar E, Muntner P, Silbergeld E, Jaar B, et al. 2009. Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol 170:1156-1164.
38. Noh JY, Park JS, Lim KM, Kim K, Bae ON, Chung SM, et al. 2010. A naphthoquinone derivative can induce anemia through phosphatidylserine exposuremediated erythrophagocytosis. J Pharmacol Exp Ther 333:414-420.
39. Otogawa K, Kinoshita K, Fujii H, Sakabe M, Shiga R, Nakatani K, et al. 2007. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steato hepatitis. Am J Pathol 170:967-980.
40. Patra RC, Swarup D, Dwivedi SK. 2001. Antioxidant effects of α tocopherol, ascorbic acid and l-methio-nine on lead induced oxidative stress to the liver, kidney and brain in rats. Toxicology 162:81-88.
41. Rasmussen ML, Folsom AR, Catellier DJ, Tsai MY, Garg U, Eckfeldt JH. 2001. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk In Communities (ARIC) study. Atherosclerosis 154:739-746.
42. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. 1994. HK-2: an immor-talized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45:48-57.
43. Schütz A, Bergdahl IA, Ekholm A, Skerfving S. 1996. Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls. Occup Environ Med 53:736-740.
44. Sheerin NS, Sacks SH, Fogazzi GB. 1999. In vitro erythro phagocytosis by renal tubular cells and tubular toxicity by haemoglobin and iron. Nephrol Dial Transplant 14:1391-1397.
45. Shettihalli AK, Gummadi SN. 2013. Biochemical evidence for lead and mercury induced transbilayer movement of phospholipids mediated by human phospholipid scramblase 1. Chem Res Toxicol 26:918-925.
46. Stacchiotti A, Morandini F, Bettoni F, Schena I, Lavazza A, Grigolato PG, et al. 2009. Stress proteins and oxidative damage in a renal derived cell line exposed to inorganic mercury and lead. Toxicology 264:215-224.
47. Thiébault C, Carriere M, Milgram S, Simon A, Avoscan L, Gouget B. 2007. Uranium induces apoptosis and is genotoxic to normal rat kidney (NRK-52E) proximal cells. Toxicol Sci 98:479-487.
48. Trump BF, Tisher CC, Saladino AJ. 1969. The nephron in heath and disease. In: The Biological Basis of Medicine, Vol. 6 (Bittar E, Bittar N, eds). London: Academic Press Inc., 387-494.
49. Valko M, Morris H, Cronin MT. 2005. Metals, toxicity and oxidative stress. Curr Med Chem 12:1161-1208.
50. Vallon V, Thomson SC. 2012. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol 74:351-375.
51. Wang H, Nishiya K, Ito H, Hosokawa T, Hashimoto K, Moriki T. 2001. Iron deposition in renal biopsy specimens from patients with kidney diseases. Am J Kidney Dis 38:1038-1044.
52. Wang L, Li J, Li J, Liu Z. 2010. Effects of lead and/or cadmium on the oxidative damage of rat kidney cortex mitochondria. Biol Trace Elem Res 137:69-78.
53. Wang L, Wang H, Hu M, Cao J, Chen D, Liu Z. 2009. Oxidative stress and apoptotic changes in primary cultures of rat proximal tubular cells exposed to lead. Arch Toxicol 83:417-427.
54. Wang L, Wang H, Li J, Chen D, Liu Z. 2011. Simultaneous effects of lead and cadmium on primary cultures of rat proximal tubular cells: interaction of apoptosis and oxidative stress. Arch Environ Contam Toxicol 61:500-511.
55. Willekens FL, Werre JM, Kruijt JK, Roerdinkholder- Stoelwinder B, Groenen-Döpp YA, van den Bos AG, et al. 2005. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 105:2141-2145.
56. Zager RA, Johnson AC, Hanson SY. 2004. Parenteral iron nephrotoxicity: potential mechanisms and consequences. Kidney Int 66:144-156.
57. Zager RA, Johnson AC, Hanson SY, Wasse H. 2002. Parenteral iron formulations: a comparative toxico-logic analysis and mechanisms of cell injury. Am J Kidney Dis 40:90-103.
58. Zhao W, Chen SS, Chen Y, Ahokas RA, Sun Y. 2008. Kidney fibrosis in hypertensive rats: role of oxidative stress. Am J Nephrol 28:548-554.